Chemotherapy Foundation Symposium XXVI: Innovative cancer therapy for tomorrow - Systemic ADH-I (Exherin) and melphalan (Alkeran) for isolated limb infusion in advanced extremity in-transit melanoma

Marvin M. Goldenberg, Douglas S. Tyler

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Chemotherapy Foundation Symposium XXVI: Innovative cancer therapy for tomorrow - Systemic ADH-I (Exherin) and melphalan (Alkeran) for isolated limb infusion in advanced extremity in-transit melanoma'. Together they form a unique fingerprint.